{"id":"W4399933845","doi":"10.1016/s1470-2045(24)00255-9","title":"Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Izaak Walton Killam Health Centre; Princess Margaret Cancer Centre","funders":"National Institutes of Health; Children’s Oncology Group; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Rhabdomyosarcoma; Temsirolimus; Chemotherapy; Oncology; Internal medicine; Pediatrics; Sarcoma; Discovery and development of mTOR inhibitors; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008638298,0.0002896659,0.001137928,0.0001124678,0.00009104468,0.00004855012,0.0004052698,0.0001774695,0.00009281412],"category_scores_gemma":[0.0001248549,0.000147298,0.00007518807,0.000298946,0.0002807766,0.00007911312,0.0001625077,0.0005128651,0.00001640439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002382677,"about_ca_system_score_gemma":0.0001914253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002144989,"about_ca_topic_score_gemma":0.001624156,"domain_scores_codex":[0.9977142,0.0006501047,0.0005178174,0.0005172649,0.0002081763,0.0003924404],"domain_scores_gemma":[0.998201,0.0008985051,0.0002242281,0.0005137732,0.00004160299,0.0001209104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5144861,0.006158247,0.1733887,0.00003056991,0.0009746948,0.0001652421,0.002939947,9.423645e-7,0.0001588867,0.0001346986,0.006850047,0.2947118],"study_design_scores_gemma":[0.5706971,0.01138534,0.412328,0.0006576752,0.0004893482,0.0002599896,0.0001872974,0.00009210566,0.0001177649,0.0001441039,0.003486842,0.0001543889],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832973,0.002493327,0.00002620477,0.007265888,0.000338609,0.005919752,0.0004328874,0.00004720665,0.0001787957],"genre_scores_gemma":[0.9910155,0.00312855,0.0004273777,0.002856976,0.001170693,0.001071512,0.0002768979,0.0000419961,0.00001049454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2945574,"threshold_uncertainty_score":0.6006638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02165002668722171,"score_gpt":0.3291325067953292,"score_spread":0.3074824801081075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}